In the quest for reduced morbidity from radical treatments, tissue-sparing focal therapies are being developed to treat men with localized prostate cancer. However, which patients are most suitable ...

D.C.-based Localized this week announced the close of a $1.2 million funding round. The startup uses technology to bring career guidance to college students in emerging markets. The multilingual ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Between 1999 and 2009 in the United Kingdom, 82,429 men between 50 and 69 years of age underwent prostate-specific antigen (PSA) testing as part of the Prostate Testing for Cancer and Treatment ...

Consensus on Screening, Diagnosis, and Staging Tools for Prostate Cancer in Developing Countries: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC) The ...

In localized MSI-H colon and rectal cancers, neoadjuvant immunotherapy has demonstrated unprecedented efficacy, yielding near-universal major pathologic responses and high rates of pathologic complete ...